Effects of pH on opioid receptor activation and implications for drug design. [PDF]
Stein C.
europepmc +1 more source
Opioid Analgesia Following Pediatric Adenotonsillectomy: A Randomized Clinical Trial
Abstract Objective To compare the safety and efficacy of nonopioid versus opioid pain management following adenotonsillectomy (AT) among pediatric patients. Study Design An open‐label randomized controlled trial. Setting Tertiary care children's hospital. Methods Patients aged 3 to 17 years undergoing AT were eligible.
Rachel L. Whelan+13 more
wiley +1 more source
Differential temporal decline of cerebral oxytocin and μ-opioid receptor density during the aging process in mice. [PDF]
Effah F+6 more
europepmc +1 more source
Steroids for Pediatric Adenotonsillectomy Pain—A Prospective Multicenter Randomized Trial
Abstract Objective To compare postoperative caregiver‐reported pain control of two steroid regimens following pediatric adenotonsillectomy. Secondary objectives assessed differences in analgesic use, return to normal diet, caregiver calls, adverse effects, and emergency room (ER) visits. Study Design Prospective randomized pragmatic trial.
Kevin D. Pereira+7 more
wiley +1 more source
<i>O</i>-Desmethyltramadol Enhanced Anti-Cancer Efficacy over Tramadol Through Non-μ-Opioid Receptor and Differential Cellular Contexts of Human Breast Cancer Cells. [PDF]
Wu ZS, Huang YH, Huang SM.
europepmc +1 more source
Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations [PDF]
Bunten, Hannah+3 more
core
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk+5 more
wiley +1 more source
Abstract Background Oxaliplatin‐induced peripheral neuropathy (OIPN) is a major clinical challenge because it leads to discontinuation of chemotherapy. Omeprazole, a proton pump inhibitor (PPI), has been shown to prevent OIPN in a rat model. Therefore, we aimed to test whether the concomitant use of a PPI reduces oxaliplatin discontinuation due to OIPN.
Keisuke Mine+14 more
wiley +1 more source
Gene polymorphism Mu opioid receptor & its impact on naltrexone treatment response in alcohol-dependent individuals: A pilot study from north India. [PDF]
Quraishi R+4 more
europepmc +1 more source
ABSTRACT This study describes one district's experience having counselors deliver, for the first time, a school‐based treatment to address student trauma symptoms. After their initial training, school counselors rated Bounce Back (K‐5th grade) and Support for Students Exposed to Trauma (5th−12th grade) as highly acceptable and anticipated a positive ...
Yourdanos Bekele+3 more
wiley +1 more source